-
U.S. Preventive Services Task Force. Unhealthy Drug Use: Screening. June 9, 2020.
-
SAMHSA/CSAT. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. 2004. PMID: 22514846.
-
SAMHSA. Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update. Winter 2016.
-
ASAM. The ASAM National Practice Guideline For the Treatment of Opioid Use Disorder 2020 Focused Update. 2020.
-
FSMB. Model Policy on DATA 2000 and Treatment of Opioid Addiction in the Medical Office. FSMB Website. 2013.
-
Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: A Rapid Review. J Gen Intern Med. December 2020;35(Suppl 3):954-963. doi:10.1007/s11606-020-06257-4. PMCID: PMC7728943. PMID: 33145687.
-
NIDA. Screening for Substance Use. Natl Inst Drug Abuse. 2020.
-
Walden G. Text – H.R.6 – 115th Congress (2017-2018): SUPPORT for Patients and Communities Act. October 4, 2018.
-
American Psychiatric Association. Substance-Related and Addictive Disorders. APA. 2013.
-
Shah M, Huecker MR. Opioid Withdrawal. In: StatPearls. Vol Treasure Island (FL): StatPearls Publishing; 2020. PMID: 30252268.
-
Greene MS, Chambers RA. Pseudoaddiction: Fact or Fiction? An Investigation of the Medical Literature. Curr Addict Rep. 2015;2(4):310-317. doi:10.1007/s40429-015-0074-7. PMCID: PMC4628053. PMID: 26550549.
-
Chou R, Fanciullo GJ, Fine PG, et al. Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. J Pain Off J Am Pain Soc. February 2009;10(2):113-130. doi:10.1016/j.jpain.2008.10.008. PMCID: PMC4043401. PMID: 19187889.
-
Smith P, Schmidt S, Allensworth-Davies D, et al. A Single-Question Screening Test for Drug Use in Primary Care. Arch Intern Med. 2010;170(13):1155-1160. PMCID: PMC2911954. PMID: 20625025.
-
UMBCtube. SBIRT: Screen for Substance Use – Negative Screen. UMBCtube; 2011.
-
McNeely J, Wu L-T, Subramaniam G, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. November 15, 2016;165(10):690. doi:10.7326/M16-0317.
-
Mdege N, Lang J. Screening Instruments for Detecting Illicit Drug Use Abuse That Could Be Useful in General Hospital Wards: A Systematic Review. Addict Behav. 2011;36:1111-1119. PMID: 21821364.
-
Brown R, Leonard T, Saunders L, et al. The Prevalence and Detection of Substance Use Disorder among Inpatients Ages 18 to 49: An Opportunity for Prevention. Prev Med. 1998;27:101-110. PMID: 9465360.
-
Babor T, Higgins-Biddle J, Saunders J, et al. AUDIT: The Alcohol Use Disorders Identification Test Guidelines for Use in Primary Care. Vol Second edition. World Health Organization, Department of Mental Health and Substance Dependence; 2001.
-
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Vol 5th edition. Washington, DC: Author; 2013.
-
Trachtenberg A, Fleming M. Diagnosis and Treatment of Drug Abuse in Family Practice. 1994.
-
Sullivan J, Sykora K, Schneiderman J, et al. Assessment of Alcohol Withdrawal: The Revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict. 1989;84(11):1353-1357. PMID: 2597811.
-
Miller WR, Rollnick S. Motivational Interviewing: Helping People Change, 3rd Edition. Vol 3rd edition. New York, NY: The Guilford Press; September 7, 2012.
-
Lundahl B, Moleni T, Burke B, et al. Motivational Interviewing in Medical Care Settings: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 93. 2013;2:157-168. PMID: 24001658.
-
Miller W, Rollnick S. An Overview of Motivational Interviewing. 2011.
-
Magill M, Stout R, Apodaca T. Therapist Focus on Ambivalence and Commitment: A Longitudinal Analysis of Motivational Interviewing Treatment Ingredients. Psychol Addict Behav. 2013;27:754-762.
-
Clinical Tools, Inc. Motivational Interviewing: Managing Challenging Patient Behavior. Chapel Hill, NC: Clinical Tools, Inc.; 2016.
-
Schulz JE, Parran T Jr. Principles of Identification and Intervention. In: Principles of Addiction Medicine. Vol 2nd ed. Chevy Chase, Md.: American Society of Addiction Medicine; 1998:250-251.
-
SAMHSA. Screening, Brief Intervention, and Referral to Treatment (SBIRT). 2014.
-
SAMHSA. Talking with Your Adult Patients about Alcohol, Drug, and/or Mental Health Problems. Publ Digit Prod. August 2010.
-
Pickett M, Rogers P, Cavanaugh Jr R. Screening for alcohol, tobacco, and drug use in children and adolescents. In: In: Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB, Eds. Principles of Addiction Medicine. Vol Third Edition. Chevy Chase, Md: American Society of Addiction Medicine; 2003.
-
American Academy of Pediatrics. Alcohol Use by Youth and Adolescents: A Pediatric Concern. Pediatrics. 2010;125(5):1078-1087.
-
Kaul P, Coupey S. Clinical Evaluation of Substance Abuse. Pediatr Rev. March 2002;23(3):85-94. PMID: 11875181.
-
Knight J, Shrier L, Bravender T, et al. A New Brief Screen for Adolescent Substance Abuse. Arch Pediatr Adolesc Med. 1999;153(6):591-596.
-
Marshal MP, Molina BSG, Pelham WE. Childhood ADHD and Adolescent Substance Use: An Examination of Deviant Peer Group Affiliation as a Risk Factor. Psychol Addict Behav J Soc Psychol Addict Behav. December 2003;17(4):293-302. doi:10.1037/0893-164X.17.4.293. PMCID: PMC3652274. PMID: 14640825.
-
Al-Tayyib A, Rice E, Rhoades H, et al. Association between Prescription Drug Misuse and Injection among Runaway Homeless Youth. Drug Alcohol Depend. 2013;134:406-409. PMCID: PMC3886282. PMID: 24300900.
-
Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT). A Guide to Substance Abuse Services for Primary Care Clinicians. Rockville, Md: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; 2008.
-
Tamm L, Trello-Rishel K, Riggs P, et al. Predictors of Treatment Response in Adolescents with Comorbid Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder. Subst Abuse Treat. 2013;44(2):224-230. PMCID: PMC3499678. PMID: 22889694.
-
Warden D, Riggs PD, Min S-J, et al. Major Depression and Treatment Response in Adolescents with ADHD and Substance Use Disorder. Drug Alcohol Depend. August 31, 2011;120(1-3):214-219. PMCID: PMC3245790. PMID: 21885210.
-
Cirone S. Brief Intervention: Adolescent with Prescription Opioid Use Disorder. 2013.
-
Dowell D, Haegerich T, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49. doi:10.15585/mmwr.rr6501e1er.
-
Madras B, Wilson M, Avula D, et al. Screening, Brief Interventions, Referral to Treatment (SBIRT) for Illicit Drug and Alcohol Use at Multiple Healthcare Sites: Comparison at Intake and Six Months. Drug Alcohol Depend. 2010;99(1-3):280-295. PMCID: PMC2760304. PMID: 18929451.
-
Food and Drug Administration (FDA). Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS). Initial REMS / , updated 6/2015 2013.
